K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 27 03 2024
revised: 08 05 2024
accepted: 08 05 2024
medline: 28 5 2024
pubmed: 28 5 2024
entrez: 28 5 2024
Statut: epublish

Résumé

The ubiquitin (Ub) code denotes the complex Ub architectures, including Ub chains of different lengths, linkage types, and linkage combinations, which enable ubiquitination to control a wide range of protein fates. Although many linkage-specific interactors have been described, how interactors are able to decode more complex architectures is not fully understood. We conducted a Ub interactor screen, in humans and yeast, using Ub chains of varying lengths, as well as homotypic and heterotypic branched chains of the two most abundant linkage types-lysine 48-linked (K48) and lysine 63-linked (K63) Ub. We identified some of the first K48/K63-linked branch-specific Ub interactors, including histone ADP-ribosyltransferase PARP10/ARTD10, E3 ligase UBR4, and huntingtin-interacting protein HIP1. Furthermore, we revealed the importance of chain length by identifying interactors with a preference for Ub3 over Ub2 chains, including Ub-directed endoprotease DDI2, autophagy receptor CCDC50, and p97 adaptor FAF1. Crucially, we compared datasets collected using two common deubiquitinase inhibitors-chloroacetamide and N-ethylmaleimide. This revealed inhibitor-dependent interactors, highlighting the importance of inhibitor consideration during pulldown studies. This dataset is a key resource for understanding how the Ub code is read.

Identifiants

pubmed: 38803224
pii: 7/8/e202402740
doi: 10.26508/lsa.202402740
pii:
doi:

Substances chimiques

Ubiquitin 0
Lysine K3Z4F929H6
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Waltho et al.

Auteurs

Anita Waltho (A)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany aswaltho@hotmail.com.
Institute for Biology, Humboldt-University zu Berlin, Berlin, Germany.

Oliver Popp (O)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Christopher Lenz (C)

Institute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany.

Lukas Pluska (L)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Institute for Biology, Humboldt-University zu Berlin, Berlin, Germany.

Mahil Lambert (M)

Institute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany.

Volker Dötsch (V)

Institute for Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany.

Philipp Mertins (P)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Thomas Sommer (T)

Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany tsommer@mdc-berlin.de.
Institute for Biology, Humboldt-University zu Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH